课题基金 / 基金详情

Recovery of Bluetongue Virus from nucleic acid: configuration optimisation and application

Recovery of Bluetongue Virus from nucleic acid: configuration optimisation and application
核酸回收蓝舌病毒:构型优化及应用
批准号:
BB/F007159/1
负责人:
Polly Roy
金额:
$75.54万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Polly Roy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bluetongue is a viral disease of sheep (sometimes cattle and goats) that poses an economic threat to UK agriculture. Since 1998, outbreaks of Bluetongue have spread Northwards in Europe and last year the disease reached Holland. The problem of BTV is clearly growing and the use of modern genetic methods to improve vaccines as well as to understand every aspect of the replication cycle is required. A significant bottleneck however, is the inability to recover BTV from sequence defined clones. As a result, the ability to change or delete essential genes in the virus with a view to producing attenuated strains as candidate vaccines is currently impossible. This project seeks to rectify this and produce a 'reverse genetics' system for BTV. Within the last year the research team has discovered a way to recover Bluetongue virus starting from just the viral genetic material isolated from the virus. The proposed research builds on this success to test ways in which the virus can be constructed completely from cloned gene copies and then deliberately weakened to make better vaccines. The research will specifically target the strain of virus that was the cause of last year's outbreak in Holland to make new strains that can be used to protect UK livestock against this disease. If successful it may be possible to also apply the research to make better vaccines for other viruses which cause disease in human and horses.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/1743-422x-9-178
发表时间: 2012-08-29
期刊: Virology journal
影响因子: 4.8
作者: [Boyce M, Celma CC, Roy P]
通讯作者: Roy P
The RNA interactome necessary and sufficient for Orbivirus genome packaging
Development of a highly sensitive serological assay for Covid-19 based on the use of virus-like particles and protein-based nanoparticles.
Realising the potential of a safe and protective universal vaccine for African horse sickness disease
Unravelling a tangle: how segmented double-stranded RNA viruses package their genome
海外基金